BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25318603)

  • 1. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.
    Bissolati M; Sandri MT; Burtulo G; Zorzino L; Balzano G; Braga M
    Tumour Biol; 2015 Feb; 36(2):991-6. PubMed ID: 25318603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
    Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
    Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
    Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
    Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
    Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
    Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
    Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications.
    Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Pancreatology; 2021 Jan; 21(1):103-114. PubMed ID: 33309014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
    Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
    Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
    Connor AA; McNamara K; Al-Sukhni E; Diskin J; Chan D; Ash C; Lowes LE; Allan AL; Zogopoulos G; Moulton CA; Gallinger S
    Ann Surg Oncol; 2016 Jul; 23(7):2168-75. PubMed ID: 26714949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer.
    Liu X; Li C; Li J; Yu T; Zhou G; Cheng J; Li G; Zhou Y; Lou W; Wang X; Gong G; Liu L; Chen Y
    J Cancer; 2018; 9(11):2038-2045. PubMed ID: 29896289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique localization of circulating tumor cells in patients with hepatic metastases.
    Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; Stebbing J
    J Clin Oncol; 2009 Dec; 27(36):6160-5. PubMed ID: 19884529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers.
    Chapman CG; Ayoub F; Swei E; Llano EM; Li B; Siddiqui UD; Waxman I
    Pancreatology; 2020 Dec; 20(8):1747-1754. PubMed ID: 33082106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer.
    Choi YH; Hong TH; Yoon SB; Lee IS; Lee MA; Choi HJ; Choi MH; Jung ES
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
    Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.